Aria CV
St. Paul, US · Founded 2010 · Delaware corporation · 4 known investors
BiotechHealthtech
Founders & leadership
JW
Joshua WoolleyExecutive
RG
Ryan GladneyExecutive
GG
Gary GrahamExecutive
DW
Dan W. GladneyExecutive
PD
Peter DeLangeExecutive
KV
Karl VollmersNamed on SEC filing
JS
John ScandurraNamed on SEC filing
JG
John GainorNamed on SEC filing
BA
Bruce A. MachmeierNamed on SEC filing
RF
Robert F. WilsonNamed on SEC filing
ND
Norman DannNamed on SEC filing
Board
DZ
Investors · 4
Reported raises · per SEC filings
Form D private placements$13.9M disclosed across 5 of 6 rounds · 2014–2025
▶$1.4MraisedAug 2025 · 39 investors · Other Health CareRule 506(b)
▶$1.4MraisedAug 2025 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott WardDirector
- Steven YakubovDirector
- Dan W. GladneyExecutive Officer, Director
- George FazioDirector
- Darshana ZaveriDirector
- Renee MasiDirector
- Karl VollmersExecutive Officer
- John ScandurraExecutive Officer
- Peter DeLangeExecutive Officer
- Offering amount
- $6M
- Amount sold
- $1.4M
- Sales commissions
- $136.6K
- Proceeds to insiders
- $1M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedSep 2024 · 33 investors · Other Health CareRule 506(b)
▶$2.2MraisedSep 2024 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Karl VollmersExecutive Officer
- John ScandurraExecutive Officer
- Joshua WoolleyExecutive Officer
- Ryan GladneyExecutive Officer
- Darshana ZaveriDirector
- Steven Yakubov, MDDirector
- Renee MasiDirector
- Maria Berkman, MDDirector
- George FazioDirector
- Gary GrahamExecutive Officer
- Dan W. GladneyExecutive Officer, Director
- Peter DeLangeExecutive Officer
- Jason RushtonDirector
- Offering amount
- $20M
- Amount sold
- $2.2M
- Sales commissions
- $266.3K
- Proceeds to insiders
- $1.9M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedJul 2022 · 23 investors · Other Health CareRule 506(b)
▶$7.8MraisedJul 2022 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Spencer KuboExecutive Officer
- Renee MasiDirector
- George FazioDirector
- John ScandurraExecutive Officer
- Peter DeLangeExecutive Officer
- Jason RushtonDirector
- Darshana ZaveriDirector
- Maria BeckmanDirector
- Dan W. GladneyExecutive Officer, Director
- Gary GrahamExecutive Officer
- Offering amount
- $13M
- Amount sold
- $7.8M
- Sales commissions
- $139.8K
- Proceeds to insiders
- $1.9M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$666.6KraisedJan 2020 · 10 investors · Other Health CareRule 506(b)
▶$666.6KraisedJan 2020 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Renee MasiDirector
- John ScandurraExecutive Officer
- Richard SchroederExecutive Officer
- Darshana ZaveriDirector
- Maria BeckmanDirector
- Marc KnutsonExecutive Officer
- Dan W. GladneyExecutive Officer, Director
- Karl VollmersExecutive Officer
- Offering amount
- $18M
- Amount sold
- $666.6K
- Sales commissions
- $300K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedMar 2018 · 8 investors · BiotechnologyRule 506(b)
▶$1.9MraisedMar 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Renee MasiDirector
- Darshana ZaveriDirector
- John ScandurraExecutive Officer, Director
- Dan W. GladneyDirector
- Karl VollmersExecutive Officer
- John GainorExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1.9M
- Minimum investment
- $100K
- Sales commissions
- $75K
- Proceeds to insiders
- $60K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MofferedDec 2014 · BiotechnologyRule 506(b)
▶$6.3MofferedDec 2014 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce A. MachmeierExecutive Officer
- Robert F. WilsonDirector
- John ScandurraExecutive Officer, Director
- Norman DannDirector
- Dan W. GladneyDirector
- Karl VollmersExecutive Officer
- Offering amount
- $6.3M
- Minimum investment
- $75K
- Sales commissions
- $127.5K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapOsfhealthcare4 shared keywordsOSF HealthCare is a health care provider operating hospitals and clinics across Illinois and Michigan, offering services including cancer treatments such as proton therapy and brachytherapy, digital health through OSF OnCall, and clinical research. It also runs OSF Innovation and provides patient tools like the My OSF mobile app and OSF MyChart.
Rf Surgical4 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Massdevice3 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Companies competing with Aria CV for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are Aria CV's investors?
- Aria CV's investors include Angel Physicians Fund, Brightstone Venture Capital, Broadview Ventures, Portfolia.
- How much funding has Aria CV raised?
- Aria CV has disclosed $13.9M raised across 5 of its 6 known rounds.
- Where is Aria CV headquartered?
- Aria CV is headquartered in St. Paul, US.